Michael McClellan

2017

In 2017, Michael McClellan earned a total compensation of $1.1M as Executive Vice President, Chief Financial Officer at Teva Pharmaceutical Industries.

Compensation breakdown

Bonus$101,250
Option Awards$195,515
Salary$397,058
Stock Awards$199,260
Other$199,579
Total$1,092,662

McClellan received $397.1K in salary, accounting for 36% of the total pay in 2017.

McClellan also received $101.3K in bonus, $195.5K in option awards, $199.3K in stock awards and $199.6K in other compensation.

Rankings

In 2017, Michael McClellan's compensation ranked 8,567th out of 14,666 executives tracked by ExecPay. In other words, McClellan earned more than 41.6% of executives.

ClassificationRankingPercentile
All
8,567
out of 14,666
42nd
Division
Manufacturing
3,250
out of 5,772
44th
Major group
Chemicals And Allied Products
1,085
out of 2,075
48th
Industry group
Drugs
859
out of 1,731
50th
Industry
Pharmaceutical Preparations
670
out of 1,333
50th
Source: SEC filing on April 25, 2018.

McClellan's colleagues

We found nine more compensation records of executives who worked with Michael McClellan at Teva Pharmaceutical Industries in 2017.

2017

Kåre Schultz

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Yitzhak Peterburg

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Rob Koremans

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Carlo de Notaristefani

Teva Pharmaceutical Industries

Executive Vice President, Global Operations

2017

Michael Hayden

Teva Pharmaceutical Industries

Chief Scientific Officer

2017

Eyal Desheh

Teva Pharmaceutical Industries

Chief Financial Officer

2017

Hafrun Fridriksdottir

Teva Pharmaceutical Industries

Executive Vice President, Global Research and Development

2017

Erez Vigodman

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Mark Sabag

Teva Pharmaceutical Industries

Executive Vice President, Global Human Resources

News

You may also like